Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Merges Agencourt and Cogenics into Beckman Coulter Genomics


By Julia Karow

Beckman Coulter said last week that it has combined Agencourt Bioscience and recently acquired Cogenics to form Beckman Coulter Genomics.

The new Beckman unit, which offers genomic services such as sequencing, sample prep, genotyping, gene expression, and biological efficiency and safety testing, is headquartered in Beverly, Mass., where Agencourt is located.

The company offers next-generation sequencing services on the 454 GS FLX, Applied Biosystems SOLiD, and Illumina Genome Analyzer platforms, as well as Sanger sequencing.

It also supports "all levels of regulatory compliance," including Clinical Laboratory Improvement Amendments, according to a statement from Beckman.

Beckman Coulter announced its acquisition of Cogenics from Clinical Data, which closed this spring, in April and said at the time that Cogenics would add more services, a wider geographic reach, and a CLIA-certified lab to its genomics business (see In Sequence 4/7/2009).

Cogenics had facilities in Texas, North Carolina, France, the UK, and Germany, combining former operations of Genaissance, Lark, Icoria, Genome Express, and Epidauros.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.